Table 2.
Variables | No. of cases | HMGB2 expression | P value | |
---|---|---|---|---|
Low | High | |||
Age (year) | ||||
< 50 | 15 | 4 | 11 | 0.273 |
≥ 50 | 14 | 5 | 9 | |
Family history of malignant tumors | ||||
Yes | 3 | 1 | 2 | 0.460 |
No | 26 | 8 | 18 | |
P16 expression | ||||
Positive | 29 | 9 | 20 | |
Negative | 0 | 0 | 0 | |
Primary tumor size(cm) | ||||
< 3 | 7 | 5 | 2 | 0.015* |
≥ 3 | 22 | 4 | 18 | |
Pelvic lymph node metastasis | ||||
Positive | 8 | 2 | 6 | 0.325 |
Negative | 21 | 7 | 14 | |
Infiltration depth | ||||
Superficial/Deep fibrous histiocytoma | 18 | 8 | 10 | 0.048* |
Outer layer of the cervix | 11 | 1 | 10 | |
The FIGO stage | ||||
Ia-Ib1 | 15 | 8 | 7 | 0.009* |
Ib2-IIa2 | 14 | 1 | 13 |
*P < 0.05
FIGO International Federation of Gynecology and Obstetrics